Credent Connect N Care Ltd. IPO

Credent Connect N Care Limited is a healthcare services provider engaged in delivering integrated logistics, workforce solutions and technology-enabled support to healthcare institutions across India. The company serves diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, hospitals, clinics and other healthcare enterprises.

The company was incorporated in 2015 as Credent Cold Chain Logistics Private Limited. It was subsequently renamed Credent Connect N Care Limited. The company's registered office is located at B-3, Second Floor, Nimri Commercial Complex, Ashok Vihar, Phase-4, New Delhi.

Credent's business model combines healthcare logistics with technology-enabled operational support. Its services include transportation of diagnostic samples, reagent movement for IVD companies, workforce deployment, courier aggregation and other logistics and operational services for healthcare institutions.

The company provides B2B healthcare logistics services involving the transportation of diagnostic samples from collection points to laboratories and between healthcare facilities. It also provides services to IVD companies for movement of reagents from their carrying and forwarding locations to laboratories.

Credent has also developed technology-enabled logistics capabilities. Its C3 Post platform provides courier aggregation and supports bulk shipping with pan-India pin-code coverage, according to company and IPO-related disclosures.

The company's operations are supported by a geographically distributed workforce and logistics infrastructure. Its customer base includes healthcare and allied businesses that require regular movement of samples, reagents, supplies and other materials.

The company has expanded its healthcare ecosystem through subsidiaries and acquisitions, including Credent Healthcare Private Limited, Credent Team Private Limited and Alltrak Technologies Private Limited.

Credent Healthcare Private Limited is particularly relevant to the IPO because part of the issue proceeds is proposed to be invested in the subsidiary for working capital and capital expenditure requirements for machinery.

The company's business is working-capital intensive. Trade receivables represented a significant portion of current assets, making timely collection from customers important for liquidity and cash-flow management.

Credent's operations also depend on a large field workforce. Employee retention, service quality, route management and operational discipline are therefore important to maintaining service levels for healthcare customers.

Credent Connect N Care operates at the intersection of healthcare services and logistics. Its business provides operational support to diagnostic laboratories, IVD companies, pharmaceutical companies, hospitals and other healthcare institutions. This specialised focus differentiates the company from a conventional general-purpose logistics operator.

The company's services include transportation of diagnostic samples, movement of IVD reagents, workforce deployment, courier aggregation and other healthcare logistics activities. The ability to manage time-sensitive healthcare movements is an important component of its business model.

The company has also expanded through subsidiaries and acquisitions, including Credent Healthcare Private Limited. The IPO itself proposes a ₹29.80 crore investment into this subsidiary, consisting of ₹26.80 crore for working capital and ₹3.00 crore for machinery-related capital expenditure.

Financial performance showed substantial improvement in FY2026. Revenue from operations increased from ₹77.94 crore in FY2025 to ₹214.16 crore in FY2026, while total income increased from ₹78.23 crore to ₹214.43 crore. Profit after tax increased from ₹2.25 crore to ₹18.45 crore.

The increase in revenue and profitability was significant, but investors should assess whether the FY2026 growth rate can be sustained because a substantial portion of the expansion came in a single financial year.

The company reported FY2026 ROE of 61.81%, ROCE of 40.00%, RoNW of 42.13%, PAT margin of 8.61%, EBITDA margin of 13.29% and debt-to-equity of 0.50.

At the upper issue price of ₹189, the reported pre-IPO EPS was ₹13.92 and post-IPO EPS was ₹10.12. This translated into a pre-IPO P/E of 13.58x and a post-IPO P/E of 18.68x.

The IPO proceeds are heavily focused on working capital. ₹37.00 crore is earmarked for the company's working capital and another ₹26.80 crore is proposed for working capital at Credent Healthcare Private Limited. This reflects the working-capital-intensive nature of the business.

The company also proposed ₹6.00 crore for repayment or prepayment of borrowings. This can reduce debt obligations, although the company continues to require working capital to support its growing operations.

Customer concentration is an important factor to monitor. The company derives a significant proportion of revenue from its top customers, making customer retention and contract continuity important to future performance.

Operational execution is another important consideration. Healthcare logistics involves time-sensitive sample transportation, workforce deployment, temperature and handling requirements and compliance with customer service standards. Any disruption can affect customer relationships and operating performance.

The IPO received extremely strong demand. The final subscription reached 153.13 times, with QIBs at 130.40 times, NIIs at 216.97 times and retail investors at 138.86 times.

Credent Connect N Care shares were listed on NSE SME on 20 August 2026 at ₹359.10 against the issue price of ₹189, resulting in a listing gain of approximately 90%.

Overall, Credent Connect N Care has a specialised healthcare-logistics business, strong FY2026 financial growth, technology-enabled operations and an expanding healthcare ecosystem. At the same time, investors should consider working-capital requirements, customer concentration, workforce dependence, subsidiary performance, borrowing levels and the sustainability of recent growth before making an investment decision.

Listing Performance

Credent Connect N Care shares were listed on NSE SME on 20 August 2026 at ₹359.10 against the IPO issue price of ₹189. The shares therefore debuted at a premium of ₹170.10 per share, representing a listing gain of approximately 90%.

Credent Connect N Care IPO applications were made through the ASBA process and UPI-supported IPO applications. The market lot was 600 shares, while Individual Investors were required to apply for a minimum of 2 lots, or 1,200 shares, requiring ₹2,26,800 at the upper price band of ₹189.

Through UPI

1. Log in to your stockbroker app or website.
2. Go to the IPO section.
3. Select Credent Connect N Care IPO.
4. Enter the required number of lots.
5. Enter your valid UPI ID.
6. Submit the IPO application.
7. Approve the UPI mandate received in your UPI application.
8. Confirm the mandate using your UPI PIN.
9. The application amount remains blocked in your bank account until the allotment process.
10. The applicable amount is debited after allotment, while the remaining blocked amount is released according to the IPO process.